It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 | Hyderabad, Telangana, India | ActiveIzene Life Sciences Private Limited, a active private limited company, was established on 28 October 2011 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24232TG2011PTC077180. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Its leadership includes Syed Ahmed Ubaid (Director), Deepthi Aluri (Director), Karuna Sri Gade (Director). Past directors included Deepak Narayana Varakolu, Ratna Bhaskar Reddy Gade. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Lab Suite 211B, 450, Alexandria Knowledge Park, Genome Valley, Shameerpet, Turkapally, Hyderabad, Telangana, 500078.
U24232TG2011PTC077180
077180
28 October 2011
₹5.00 M
₹3.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Izene Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Syed Ahmed Ubaid | Director | 28 Oct 2011 | Current |
| Deepthi Aluri | Director | 27 Jan 2012 | Current |
| Karuna Sri Gade | Director | 01 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jan 2012 | Past |
| Pramod Abcsdd | Director | 04 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Izene Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 165.93% increase. The company also saw a substantial improvement in profitability, with a 65.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Izene Life Sciences had a promoter holding of 72.60% and a public holding of 27.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Izene Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Izene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Izene Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Izene Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Izene Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Karuna Sri Gade was appointed as a Director was appointed as a Director on 01 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
Deepthi Aluri was appointed as a Director was appointed as a Director on 27 Jan 2012 & has been associated with this company since 13 years 10 months . was recorded as a recent event.
Syed Ahmed Ubaid was appointed as a Director was appointed as a Director on 28 Oct 2011 & has been associated with this company since 14 years 1 month . was recorded as a recent event.
Progress on Izene Life Sciences Private Limited was registered on 28 Oct 2011 with Roc Hyderabad & aged 14 years 1 month as per MCA records. was documented.
The CIN of Izene Life Sciences Private Limited is U24232TG2011PTC077180.
Izene Life Sciences Private Limited is headquartered at Lab Suite 211B, 450, Alexandria Knowledge Park, Genome Valley, Shameerpet, Turkapally, Hyderabad, Telangana, 500078.
Izene Life Sciences Private Limited was incorporated on 28 October 2011.
The current directors of Izene Life Sciences Private Limited are
The primary industry of Izene Life Sciences Private Limited is Manufacturing.
Izene Life Sciences Private Limited is unlisted.
The authorized capital of Izene Life Sciences Private Limited is ₹5.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Izene Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX